Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants

Archive ouverte

Dennis, Jessica | Medina-Rivera, Alejandra | Truong, Vinh | Antounians, Lina | Zwingerman, Nora | Carrasco, Giovana | Strug, Lisa | Wells, Phil | Trégouët, France | Morange, France | Wilson, Michael | Gagnon, France | Albaladejo, Pierre | Samama, Marc | Sié, Pierre | Kauffmann, Sophie | Mémier, Vincent | Suchon, Pierre | Viallon, Alain | David, Stéphane | Gruel, Yves | Bellamy, Lorenn | de Maistre, Emmanuel | Romegoux, Pauline | Thoret, Sophie | Pernod, Gilles | Bosson, Jean-Luc | Bazin, Etienne | Combaret, Nicolas | Cherprenet, Anne | Fares, Moustafa | Dufraisse, Sophie | Minville, Vincent | Morange, Pierre-Emmanuel | Leone, Marc | Cohen, William | Néant, Nadège | Marlu, Raphaël | Carpentier, Françoise | Defaye, Pascal | Mismetti, Patrick | Molliex, Serge | Lanoiselée, Julien | Piriou, Vincent | Delaleu-Rague, Carine | Lefèvre, Mathilde | Lagrange, Sophie | Ardillon, Lauren | Ozier, Yves | Bovet, Julien | Steib, Annick | Mebaouj, Sonia | Profumo, Louis | Roullet, Stéphanie | Smadja, David | Meyer, Guy | Journois, Didier | Trinh-Duc, Albert | Viard, Thibault | Belle, Loic | Levrat, Albrice | Gautheron, Etienne | Heluwaert, Frédéric | Schlumberger, Sylvie | Blanié, Antonia | Benhamou, Dan | Flaujac, Claire | Rosencher, Nadia | Beloeil, Hélène | Blery, Catherine | Daviet, Lauren | Guéret, Pierre | Faraoni, David | Schved, Jean François | Deras, Pauline | Jaber, Samir | Gueugniaud, Pierre Yves | Floccard, Bernard | Asehnoune, Karim | Paulus, Jerome | Amrani, Omar | Gonthier, Marie Caroline | Huisse, Marie Geneviève | Josserand, Julien | de Raucourt, Emmanuelle | Defournel, Cécile | Dubois, Yohann | Bouvier, Stéphane | Roy, Pierre-Marie | Lasocki, Sigismond | Carmagnac, Christian | Chastagner, Catherine | Thouret, Jean Marc | Sevestre, Marie Antoinette | Meaudre, Eric | Cungi, Pierre-Julien | Susen, Sophie | Lefrant, Jean Yves | Macey, Stéphane | Rieu, Jean Baptiste | Godier, Anne

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. The use of prothrombin complex concentrates and the role of plasma concentration of anticoagulants in the management of bleeding in patients treated with direct oral anticoagulants are still debated. Our aim was to describe management strategies and outcomes of severe bleeding events in patients treated with direct oral anticoagulants.METHODS:We performed a prospective cohort study of 732 patients treated with dabigatran, rivaroxaban, or apixaban hospitalized for severe bleeding, included prospectively in the registry from June 2013 to November 2015.RESULTS:Bleeding was gastrointestinal or intracranial in 37% (212 of 732) and 24% (141 of 732) of the cases, respectively. Creatinine clearance was lower than 60 ml/min in 61% (449 of 732) of the cases. The plasma concentration of direct oral anticoagulants was determined in 62% (452 of 732) of the cases and was lower than 50 ng/ml or higher than 400 ng/ml in 9.2% (41 of 452) and in 6.6% (30 of 452) of the cases, respectively. Activated or nonactivated prothrombin complex concentrates were administered in 38% of the cases (281 of 732). Mortality by day 30 was 14% (95% CI, 11 to 16).CONCLUSIONS:Management of severe bleeding in patients treated with direct oral anticoagulants appears to be complex. The use of prothrombin complex concentrates differs depending on bleeding sites and direct oral anticoagulant plasma concentrations. Mortality differs according to bleeding sites and was similar to previous estimates.

Consulter en ligne

Suggestions

Du même auteur

Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels

Archive ouverte | Dennis, Jessica | CCSD

International audience. Tissue factor pathway inhibitor (TFPI) regulates the formation of intravascular blood clots, which manifest clinically as ischemic heart disease, ischemic stroke, and venous thromboembolism (...

Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network

Archive ouverte | Godier, Anne | CCSD

International audience. BackgroundAny surgical procedure carries a risk for venous thromboembolism (VTE), albeit variable. Improvements in medical and surgical practices and the shortening of care pathways due to th...

Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) – September 2016

Archive ouverte | Albaladejo, Pierre | CCSD

International audience. In 2013, the GIHP published guidelines for the management of severe haemorrhages and emergency surgery. This update applies to patients treated with dabigatran, with a bleeding complication o...

Chargement des enrichissements...